JP2010501576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501576A5 JP2010501576A5 JP2009525648A JP2009525648A JP2010501576A5 JP 2010501576 A5 JP2010501576 A5 JP 2010501576A5 JP 2009525648 A JP2009525648 A JP 2009525648A JP 2009525648 A JP2009525648 A JP 2009525648A JP 2010501576 A5 JP2010501576 A5 JP 2010501576A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- effective amount
- therapeutically effective
- use according
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93492406P | 2006-08-25 | 2006-08-25 | |
| PCT/US2007/018770 WO2008024485A2 (en) | 2006-08-25 | 2007-08-23 | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010501576A JP2010501576A (ja) | 2010-01-21 |
| JP2010501576A5 true JP2010501576A5 (enExample) | 2010-10-07 |
Family
ID=39107444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525648A Pending JP2010501576A (ja) | 2006-08-25 | 2007-08-23 | ビタミンｄ化合物及び追加の治療薬の投与を含む癌の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP2063963A2 (enExample) |
| JP (1) | JP2010501576A (enExample) |
| KR (1) | KR20090060306A (enExample) |
| CN (1) | CN101528309A (enExample) |
| AU (1) | AU2007287099A1 (enExample) |
| CA (2) | CA2661546A1 (enExample) |
| IL (1) | IL197212A0 (enExample) |
| NO (1) | NO20091191L (enExample) |
| WO (1) | WO2008024485A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20170434A (es) * | 2009-01-27 | 2017-11-21 | Berg Llc | VITAMINA D3 Y ANALOGOS DE LA MISMA PARA ALIVIAR EFECTOS SECUNDARIOS ASOCIADOS CON LA QUIMIOTERAPIA. (Divisional 2011-0445) |
| RS53384B (sr) | 2009-06-26 | 2014-10-31 | Novartis Ag | Derivati 1,3-disupstituisanog imidazolidin-2-on kao inhibitori cyp 17 |
| EP2453892B1 (en) * | 2009-07-16 | 2013-05-29 | Institut National de la Santé et de la Recherche Medicale | Pharmaceutical compositions and their use for treating cancer |
| JP2013537210A (ja) | 2010-09-16 | 2013-09-30 | ノバルティス アーゲー | １７α−ヒドロキシラーゼ／Ｃ１７，２０−リアーゼ阻害剤 |
| US20120116381A1 (en) | 2010-11-05 | 2012-05-10 | Houser Kevin L | Surgical instrument with charging station and wireless communication |
| JP6002210B2 (ja) | 2011-04-28 | 2016-10-05 | ノバルティス アーゲー | １７α−ヒドロキシラーゼ／Ｃ１７，２０−リアーゼ阻害剤 |
| US9801844B2 (en) * | 2012-05-24 | 2017-10-31 | The Research Foundation Of The City University Of New York | Methods and compositions for the treatment of cancer |
| UA117663C2 (uk) | 2012-09-26 | 2018-09-10 | Арагон Фармасьютікалз, Інк. | Антиандроген для лікування неметастатичного кастраційно-резистентного раку передміхурової залози |
| WO2014058785A1 (en) | 2012-10-10 | 2014-04-17 | Novartis Ag | Combination therapy |
| JOP20200097A1 (ar) * | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
| CA2909941A1 (en) | 2013-04-24 | 2014-10-30 | Salk Institute For Biological Studies | Vitamin d receptor/smad genomic circuit gates fibrotic response |
| MX2015016715A (es) | 2013-06-05 | 2016-08-08 | Salk Inst For Biological Studi | Agonistas del receptor de la vitamina d para tratar enfermedades que afectan a la actividad de cxcl12. |
| WO2019023149A1 (en) | 2017-07-24 | 2019-01-31 | Salk Institute For Biological Studies | USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES |
| BR112020007439A2 (pt) | 2017-10-16 | 2020-10-27 | Aragon Pharmaceuticals, Inc. | antiandrogênios para o tratamento de câncer de próstata resistente à castração não metastática |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120722A (en) | 1984-02-08 | 1992-06-09 | Hoffmann-La Roche Inc. | Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia |
| US4857518A (en) | 1984-10-04 | 1989-08-15 | Wisconsin Alumni Research Foundation | Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same |
| US4717721A (en) | 1985-05-30 | 1988-01-05 | Howard W. Bremer | Sidechain homo-vitamin D compounds with preferential anti-cancer activity |
| DE3666587D1 (en) | 1985-08-02 | 1989-11-30 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
| US5145846A (en) | 1988-01-20 | 1992-09-08 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| US4851401A (en) | 1988-07-14 | 1989-07-25 | Wisconsin Alumni Research Foundation | Novel cyclopentano-vitamin D analogs |
| CA1333616C (en) | 1989-03-09 | 1994-12-20 | Hector F. Deluca | 19-nor-vitamin d compounds |
| GB8915770D0 (en) | 1989-07-10 | 1989-08-31 | Leo Pharm Prod Ltd | Chemical compounds |
| DE4101953A1 (de) | 1991-01-19 | 1992-07-23 | Schering Ag | 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel |
| DE4141746A1 (de) | 1991-12-13 | 1993-06-17 | Schering Ag | 20-methyl-substituierte vitamin d-derivate |
| GB2265624B (en) * | 1992-03-31 | 1995-04-19 | British Tech Group | 17-substituted steroids useful in cancer treatment |
| US5604213A (en) | 1992-03-31 | 1997-02-18 | British Technology Group Limited | 17-substituted steroids useful in cancer treatment |
| US5547947A (en) | 1993-03-11 | 1996-08-20 | Hoffmann-La Roche Inc. | Methods of treatment |
| GB9622590D0 (en) | 1996-10-30 | 1997-01-08 | Leo Pharm Prod Ltd | Chemical compounds |
| JP2002509888A (ja) | 1998-03-27 | 2002-04-02 | オレゴン ヘルス サイエンシーズ ユニバーシティー | 腫瘍および他の過増殖性疾患の治療におけるビタミンｄおよびその類似体 |
| WO2001064251A2 (en) * | 2000-03-02 | 2001-09-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Combination chemotherapy |
| US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
-
2007
- 2007-08-23 JP JP2009525648A patent/JP2010501576A/ja active Pending
- 2007-08-23 KR KR1020097005973A patent/KR20090060306A/ko not_active Withdrawn
- 2007-08-23 WO PCT/US2007/018770 patent/WO2008024485A2/en not_active Ceased
- 2007-08-23 EP EP07837327A patent/EP2063963A2/en not_active Withdrawn
- 2007-08-23 EP EP11175046.9A patent/EP2425874A3/en not_active Withdrawn
- 2007-08-23 AU AU2007287099A patent/AU2007287099A1/en not_active Abandoned
- 2007-08-23 CA CA002661546A patent/CA2661546A1/en not_active Abandoned
- 2007-08-23 CA CA2838089A patent/CA2838089A1/en not_active Abandoned
- 2007-08-23 CN CNA2007800385939A patent/CN101528309A/zh active Pending
-
2009
- 2009-02-24 IL IL197212A patent/IL197212A0/en unknown
- 2009-03-20 NO NO20091191A patent/NO20091191L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501576A5 (enExample) | ||
| JP2010501575A5 (enExample) | ||
| JP6445123B2 (ja) | 癌を治療するための方法及び組成物 | |
| JP2012082215A5 (enExample) | ||
| ES2356408T3 (es) | Medicamento que incluye al menos un gestágeno. | |
| US8618083B2 (en) | Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer | |
| HRP20221327T1 (hr) | Niraparib, abirateron acetat i prednizon za liječenje raka prostate | |
| HRP20110129T1 (hr) | Sastavi koji sadrže kristalni trans-(+/-)-delta-9-tetrahidrokanabinol | |
| US20030092638A1 (en) | Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents | |
| CN1652798A (zh) | 连续抑制硫酸酯酶的孕激素的激素替代疗法 | |
| JP2017516802A5 (enExample) | ||
| TWI422377B (zh) | 用於促進抗癌治療活性之方法及組成物 | |
| JP2009511590A5 (enExample) | ||
| TWI441639B (zh) | 用於治療卵巢癌之包含紫杉醇之組合 | |
| US6759397B2 (en) | Ginsenoside chemotherapy | |
| CN1652799A (zh) | 只用抑制硫酸酯酶的孕激素的避孕给药方案 | |
| US20100303937A1 (en) | Novel composition to increase testosterone levels | |
| JP2019513706A5 (enExample) | ||
| CN118045089A (zh) | 呋喹替尼的药物制剂及其应用 | |
| CN115300624A (zh) | 人参皂苷联合pd-1阻断剂在制备抗头颈鳞癌药物中的应用 | |
| US20050171071A1 (en) | Menstrual cycle control and improvement of conception rates in females | |
| CN101416959A (zh) | 15-亚甲基取代穿心莲内酯衍生物在制备抗炎解热镇痛药物中的用途 | |
| JP2006508071A5 (enExample) | ||
| US11986507B1 (en) | Micronutrient composition to improve men's health | |
| CN103908453B (zh) | 泽泻醇g在制备防治肥胖病药物中的应用 |